A Double-blind, Placebo-controlled, Randomized, Parallel-group Multicenter Study of Mometasone Furoate Nasal Spray on Sleep Disturbances and Daytime Somnolence in Subjects with Symptomatic Seasonal Allergic Rhinitis
Latest Information Update: 09 Feb 2022
Price :
$35 *
At a glance
- Drugs Mometasone (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Organon
- 05 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 16 Mar 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.